PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsAngelina Jolie has ovaries and fallopian tubes removed to reduce BRCA risk

BioNews

Angelina Jolie has ovaries and fallopian tubes removed to reduce BRCA risk

Published 27 March 2015 posted in News and appears in BioNews 796

Author

Sophie McLachlan

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.

In an article in the New York Times, Angelina Jolie has revealed her decision to have her ovaries and fallopian tubes removed, in her on-going battle to reduce her risk of cancer...

In an article in the New York Times,
Angelina Jolie reveals her decision to have her ovaries and fallopian
tubes removed, in her on-going battle to reduce her risk of cancer.

Two years ago, Jolie wrote for the
same publication about her preventive mastectomy performed after identification
of a BRCA1 gene mutation which predisposed her to both breast and ovarian
cancer.

In her most recent article, Jolie
says she did not decide to have her ovaries and fallopian tubes removed 'solely because I carry
the BRCA1 gene mutation, and I want other women to hear this. A positive BRCA
test does not mean a leap to surgery.'

'The most important
thing is to learn about the options and choose what is right for you
personally,' Jolie added.

With her BRCA1 mutation carrying a 50
percent risk of ovarian cancer, Jolie had been considering preventative surgery for a while. Two weeks ago, she decided to go ahead with it
after a blood test showed slightly elevated levels of early stage cancer
markers. Further tests eventually came back clear. But Jolie remained committed
to surgery in light of both her mutation and strong family history of the
disease.

Ovarian cancer is the fifth most common cancer among women
in the UK, with over 7,000 new diagnoses a year, according to Cancer Research UK. While surgery to remove the ovaries
and fallopian tubes is less invasive than a mastectomy, its after-effects are more
severe, forcing women into an early menopause. Therefore, Jolie was keen to
point out that alternatives are available, especially for those women who have
not yet had children.

Charities hope that this recent announcement will increase awareness of ovarian cancer in women. They further anticipate a repeat of the 'Angelina effect' - the upswing in women seeking genetic testing and counselling observed after news of Jolie's double mastectomy surgery broke in 2013 (see BioNews 772).

Lester
Barr, chairman of Genesis Breast
Cancer Prevention, says that this surgical procedure 'is a very personal choice'. However,
he adds, 'it
is the only way to
be completely sure that the risk of cancer is made as small as possible'.

Cancer develops when mistakes in our
DNA lead to abnormal cells that begin dividing uncontrollably. BRCA1 and 2 genes normally act as 'tumour suppressors',producing proteins that can repair the DNA damage. Mutations in BRCA genes affect the normal functioning
of these DNA-repairing proteins, increasing the chances of developing many types of cancer.

'If women know they have BRCA gene
mutations, they can choose to take action before cancer develops, much like
Angelina has,' Katharine
Taylor, acting chief executive of Ovarian Cancer Action, commented. 'Her bravery
to announce this news publicly could save lives.'

Most cases of breast cancer are not
inherited, and less than three percent of breast cancers are due
to mutations in BRCA genes.
In the UK, women with a strong family history of breast and ovarian cancer are eligible for genetic testing on the NHS.

Related Articles

PET BioNews
News
4 June 2021 • 2 minutes read

Breast cancer drug reduces the risk of recurrence by 42 percent

by Dr Charlott Repschläger

A targeted breast cancer treatment reduces the risk of BRCA-related cancer returning or spreading after chemotherapy...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
9 January 2017 • 2 minutes read

More women get tested for breast cancer genes thanks to 'Angelina Jolie effect'

by Anastassia Bolotkova

Angelina Jolie's 2013 public announcement that she has the BRCA1 breast cancer gene led to a 64 percent increase in women seeking genetic testing for breast cancer...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
15 July 2016 • 2 minutes read

New gene mutation linked to ovarian cancer

by Isobel Steer

Scientists have identified a mutation in the gene BRIP1 that triples a woman's risk of ovarian cancer...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
6 May 2016 • 3 minutes read

More young women with cancer having BRCA testing

by Jonathan Bestwick

More than 95 percent of younger women diagnosed with early-onset breast cancer are opting for genetic testing, a study has found...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
25 April 2016 • 2 minutes read

BRCA1 mutation linked to reduced egg reserves

by Dr Katie Howe

Women with a mutation in the breast-cancer susceptibility gene BRCA1 may have reduced numbers of eggs left in their ovaries, according to a study led by Australian scientists...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
19 September 2014 • 3 minutes read

'Angelina Jolie effect' sees breast cancer gene tests double

by Jess Ware

The number of women in the UK being referred to breast cancer clinics doubled shortly after actress Angelina Jolie revealed she had a risk-reducing double mastectomy, a study has found....

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
11 September 2014 • 3 minutes read

'Offer breast cancer risk gene screening to every 30-year-old woman', says scientist who discovered BRCA1

by Dr Rachel Montgomery

A leading scientist involved in the identification of the BRCA1 gene mutation has recommended that genetic screening of the BRCA genes should be routinely offered to all women aged 30 years or over....

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
Comment
28 April 2014 • 2 minutes read

Podcast: Relative Risk - Breast Cancer and Genetics

by James Brooks

Did Angelina Jolie's famous editorial in the New York Times a year ago inspire an overemphasis on genetic risk in breast cancer? Or has it saved lives by bringing the issue out into the open?...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
Comment
28 May 2013 • 4 minutes read

Difficult decisions faced by women with a BRCA gene mutation

by Chris Jacobs

The news about Angelina Jolie opting for a double mastectomy to reduce her risk of breast cancer has undoubtedly raised concerns among women with a family history of the disease. Whilst this news has certainly raised awareness of hereditary cancer, there are two key points that it is important to emphasize...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Genomics England forms industry collaboration

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.

Find out how you can advertise here
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

1 August 2022 • 2 minutes read

First UK medical guidelines issued for trans fertility preservation

1 August 2022 • 2 minutes read

Male age has more impact on IVF birth rate than previously thought

8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Complex structures of the human heart bioengineered

8 August 2022 • 1 minute read

Brain tumour gene also linked to childhood cancers

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856